Increased intestinal absorption of cefixime by nifedipine in the rat intestinal perfusion model: Evidence for a neural regulation

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 2, 1997, Pages 738-745

  Harcouet L ^a,b   Lebrec, D ^c   Roze C ^b   Carbon, C ^b   Farinotti, R ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b BICHAT HOSPITAL   (France)

^c BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CEFIXIME; HEXAMETHONIUM; NIFEDIPINE; SALICYLIC ACID; TETRODOTOXIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MIXTURE; INTESTINE ABSORPTION; INTESTINE EPITHELIUM; INTESTINE MOTILITY; INTESTINE PERFUSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CEFIXIME; CEFOTAXIME; DRUG SYNERGISM; ENTERIC NERVOUS SYSTEM; INTESTINAL ABSORPTION; INTESTINE, SMALL; MODELS, BIOLOGICAL; NIFEDIPINE; PEPTIDE YY; PEPTIDES; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; SALICYLIC ACID; SALICYLIC ACIDS;

EID: 0030958755     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. AGNER, E., REBLING, M. AND TRAP-JANSEN, J.: Hemodynamic effects of single-dose felodipine in normal man. Drugs 29: 36-40, 1984.
2. ALTENBERG, G. A., YOUNG, G., HORTON, J. K., GLASS, D., BELLI, J. A. AND REUSS, L.: Changes in intra-or extracellular pH do not mediate P-glycoprotein-dependent multidrug resistance. Proc. Natl. Acad. Sci. USA 90: 9735-9738, 1993.
3. AMIDON, G. L. AND LEE, H. J.: Absorption of peptide and peptidomimetic drugs. Annu. Rev. Pharmacol. Toxicol. 34: 321-341, 1994.
4. + co-transport system in the Caco-2 human colon carcinoma cell line. Biochem. J. 299: 253-260, 1994.
5. BULBRING, E. AND TOMITA, T.: Properties of the inhibitory potential of smooth muscle as observed in the response to field stimulation of the guinea pig colon. J. Physiol (Lond.) 189: 299-315, 1967.
6. COMBIS, J. M. AND VINEL, J. P.: Vasodilatateurs et hypertension portale. Gastroenterol. Clin. Biol. 15: 881-887, 1991.
7. COOKE, H. J. AND REDDIX, R. A.: Neural regulation of intestinal electrolyte transport. In Physiology of the Gastrointestinal Tract, ed 3, ed. by L. R. Johnson, Raven Press, New York, chap. 63, 1994.
8. DANTZIG, A. H., DUCKWORTH, D. C. AND TABAS, L. B.: Transport mechanisms responsible for the absorption of loracarbef, cefixime, and cefuroxime axetil into human intestinal Caco-2 cells. Biochim. Biophys. Acta 1191: 7-13, 1994.
9. DANTZIG, A. H., TABAS, L. B. AND BERGIN, L.: Cefaclor uptake by the proton-dependent dipeptide transport carrier of human intestinal Caco-2 cells and comparison to cephalexin uptake. Biochim. Biophys. Acta 1112: 167-173, 1992.
10. DE PONTI, F., D'ANGELO, L., FRIGO, G. M. AND CREMA, A.: Inhibitory effects of calcium channel blockers on intestinal motility in the dog. Eur. J. Pharmacol. 168: 133-144, 1989.
11. DE PONTI, F., GIARONI, C., COSENTINO, M., LECCHINI, S. AND FRIGO, G. M.: Calcium-channel blockers and gastrointestinal motility: Basic and clinical aspects. Pharmacol. Ther. 60: 121-148, 1993.
12. - transport: Involvement in neurohumoral action. Am. J. Physiol. 245: G165-G177, 1983.
13. DUVERNE, C., BOUTEN, A., DESLANDES, A., CARBON, C. AND FARINOTTI, R.: Modification of cefixime bioavailability by nifedipine in humans: Involvement of the dipeptide carrier system. Antimicrob. Agents Chemother. 36: 2462-2467, 1992.
14. FAULKNER, R. D., FERNANDEZ, P., LAWRENCE, G., SIA, L. L., FALKOWSKI, A. J., WEISS, A. I., YACOBI, A. AND SILBER, B. M.: Absolute bioavailability of cefixime in man. J. Clin. Pharmacol. 28: 700-706, 1988.
15. GANAPATHY, V. AND LEIBACH, F. H.: Is intestinal peptide transport energized by a proton gradient? Am. J. Physiol. 249: G153-G160, 1985.
16. GASIC, S., EICHLER, H. G. AND KORN, A.: Comparative effects of verapamil, tiapamil, diltiazem and nifedipine on systemic and splanchnic hemodynamics in man. Int. J. Clin. Pharmacol. Ther. Tox. 25: 498-503, 1987.
17. GRIFFITHS, N. M., HIRST, B. H. AND SIMMONS, N. L.: Active secretion of the fluoroquinolone ciprofloxacin by human intestinal epithelial Caco-2 cell layers. Br. J. Pharmacol, 108: 575-576, 1993.
18. HADENGUE, A., LEE, S. S., KOSHY, A., GIROD, C. AND LEBREC, D.: Regional blood flows by the microsphere method: Reproducibility in portal hypertensive rats and influence of a portal vein catheter (49689). Proc. Soc. Exp. Biol. Med. 187: 461-468, 1988.
19. HARCOUËT L.: Transport intestinal de β-lactamines orales: Caractérisation et modulation par les antagonistes des canaux calciques et les inhibiteurs de l'enzyme de conversion. Thèse de doctorat de l'université Paris-Sud, 1995.
20. HUNTER, J., HIRST, B. AND SIMMONS, N. L.: Drug absorption limited by P-glycoprotein-mediated secretory transport in human intestinal epithelial Caco-2 cell layers. Pharm. Res. 10: 743-749, 1993.
21. HURT, G. M., PENTO, J. T., JONES, C. W. AND JAIN, P.: Influence of calcium channel blockers on calcium uptake in isolated enterocytes. Med. Sci. Res. 21: 899-901, 1993.
22. + coupled transport of p.o. cephalosporins via dipeptide carriers in rabbit intestinal brush-border membranes: Difference of transport characteristics between cefixime and cephradine. J. Pharmacol. Exp. Ther. 247: 235-241, 1988.
23. INUI, K. I., YAMAMOTO, M. AND SAITO, H.: Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: Specific transport systems in apical and basolateral membranes. J. Pharmacol. Exp. Ther. 261: 195-201, 1992.
24. + coupled transport of cephradine via dipeptide carriers in rabbit intestinal brush-border membranes: Role of histidine residues. J. Pharmacol. Exp. Ther. 251: 745-749, 1989.
25. KIMURA, T., ENDO, H., YOSHIKAWA, M., MURANISHI, S. AND SEZAKI, H.: Carrier-mediated transport systems for aminopenicillins in rat small intestine. J. Pharm. Dyn. 1: 262-267, 1978.
26. KIMURA, T., YAMAMOTO, T., MIZUNO, M., SUGA, Y., KITADE, S. AND SEZAKI, H.: Characterization of aminocephalosporin transport across rat small intestine. J. Pharm. Dyn. 6: 246-253, 1983.
27. KRAMER, W., GUTJAHRS, U., KOWALESKI, S. AND GIRBIG, F.: Interaction of the orally active dianionic cephalosporin cefixime with the uptake system for oligopeptides and α-amino-β-lactam antibiotics in rabbit small intestine. Biochem. Pharmacol. 46: 542-546, 1993.
28. LUCAS, M.: Determination of acid surface pH in vivo in rat proximal jejunum. Gut 24: 734-739, 1983.
29. LUCAS, M. L., SCHNEIDER, W., HABERRICH, F. J. AND BLAIR, J. A.: Direct measurement by pH-microelectrode of the pH microclimate in rat proximal jejunum. Proc. R. Soc. Lond. B Biol. Sci. 192: 39-48, 1985.
30. MAEKAWA, H., TAKAGISHI, Y., IWAMOTO, K., DOI, Y., GURA, T., ITO, M., KITAMURA, K. AND FUJIMOTO, H.: Cephalexin preparation with prolonged activity. Jpn. J. Antibiot. 30: 631-638, 1977.
31. MOGARD, M. AND NYLANDER, G.: Water-ionic shifts and absorption in relation to intraintestinal hyperosmolality in the rat. Am. J. Surg. 144: 562-569, 1982.
32. MURER, H., HOPFER, U. AND KINNE, R.: Sodium/proton antiport in brush-border membrane vesicles isolated from rat small intestine and kidney. Biochem J. 154: 597-604, 1976.
33. NAKASHIMA, E., TSUJI, A., MIZUO, H. AND YAMANA, T.: Kinetics and mechanism of in vitro uptake of amino-lactam antibiotics by rat small intestine and relation with the intact-peptide transport system. Biochem. Pharmacol. 33: 3345-3352, 1984.
34. REISS, W. G., BAUER, L. A., HORN, J. R., ZIERLER, B. K, EASTERLING, T. R. AND STRANDNESS, D. E.: The effects of oral nifedipine on hepatic blood flow in humans. Clin. Pharmacol. Ther. 50: 379-384, 1991.
35. ROCHE, G.: Les nouvelles générations de céphalosporines orales: Le céfixime. J. Pharm. Clin. 1: 194-204, 1988.
36. SANTANDER, R., MENA, I., GRAMISU, M. AND VALENZUA, J. E.: Effect of nifedipine on gastric emptying and gastrointestinal motility in man. Dig. Dis. Sci. 33: 535-539, 1988.
37. SCHANKER, L. S., Tocco, D. J., BRODIE, B. B. AND HOBGEN, C. A. M.: Absorption of drugs from the small intestine. J. Pharmacol. 123: 83-88, 1958.
38. SHEIKH, S.: Neuropeptide Y and peptide YY: Major modulators of gastrointestinal blood flow and function. Am. J. Physiol. 24: G701-G715, 1991.
39. SHIAU, Y. F., FERNANDEZ, P., JACKSON, M. AND McMONAGLE, S.: Mechanisms maintaining a low-pH microclimate in the intestine. Am. J. Physiol. 11: G608-G584, 1985.
40. + coupled transport of orally active cephalosporins lacking an α-amino group across brush-border membrane vesicles from rat small intestine. J. Pharm. Pharmacol. 43: 433-135, 1991.
41. SUGAWARA, M., SAITOH, H., ISEKI, K., MIYAZAKI, K. AND ARITA, T.: Contribution of passive transport mechanisms to the intestinal absorption of β-lactam antibiotics. J. Pharm. Pharmacol. 42: 314-318, 1990.
42. SUGAWARA, M., TODA, T., ISEKI, K., MIYAZAKI, K, SHIROTO, H., KONDO, Y. AND UCHINO, J. I.: Transport characteristics of cephalosporin antibiotics across intestinal brush-border membrane in man, rat and rabbit. J. Pharm. Pharmacol. 44: 968-972, 1992.
43. SUTTER, M. C.: xThe mesenteric-portal vein in research. Pharmacol. Rev. 42: 287-325, 1990.
44. THOLLANDER, M., HELLSTRÔM, P. M. AND SVENSSON, T. H.: Dihydropyridine calcium channel antagonists disrupt migrating myoelectric complexes counteract intestinal disorders associated with morphine withdrawal diarrhea. Scand. J. Gastroenterol. 28: 137-144, 1993.
45. TSUJI, A., HIROOKA, H., TAMAI, I. AND TERASAKI, T.: Evidence for a carrier-mediated transport system in the small intestine available for FK089, a new cephalosporin antibiotic without an amino group. J. Antibiot. 39: 1592-1597, 1986.
46. TSUJI, A., HIROOKA, H., TERASAKI, T., TAMAI, I. AND NAKASHIMA, E.: Saturable uptake of cefixime, a new oral cephalosporin without an α-amino group, by the rat intestine. J. Pharm. Pharmacol. 39: 272-277, 1987a.
47. + gradient-dependent and carrier-mediated transport of cefixime, a new cephalosporin antibiotic, across brush-border membrane vesicles from rat small intestine. J. Pharmacol. Exp. Ther. 241: 594-601, 1987b.
48. + exchanger. Clin. Pharmacol. Ther. 57: 257-264, 1995.
49. WESTPHAL, J. F., TROUVIN, J. H., DESLANDES, A. AND CARBON, C.: Nifedipine enhances amoxicillin absorption kinetics and bioavailability in humans. J. Pharmacol. Exp. Ther. 255: 312-317, 1990.
50. WINNE, D.: Influence of blood flow on intestinal absorption of xenobiotics. Pharmacology (Basel) 21: 1-15, 1980.
51. YAMAOKA, K., KAMBA, M., TOYODA, Y., YANO, Y. AND NAKAGAWA, T.: Analysis of enterohepatic circulation of cefixime in rat by fast inverse Laplace transformation (FILT). J. Pharm. Biopharm. 18: 545-559, 1990.